Cannabis Science Inc (CBIS) financial statements (2022 and earlier)

Company profile

Business Address 19800 MACARTHUR BLVD., SUITE #300
IRVINE, CA 92612
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3336210124
Cash and cash equivalents3336210124
Receivables3639 77140
Inventory, net of allowances, customer advances and progress billings10319 
Inventory10319   
Other undisclosed current assets809194156225550
Total current assets:1,280315166303713
Noncurrent Assets
Property, plant and equipment   216
Long-term investments and receivables273129244225525
Long-term investments273129244225525
Intangible assets, net (including goodwill)752386 273378
Goodwill 171 6644
Intangible assets, net (excluding goodwill)752215 207334
Prepaid expense  4,4493,553
Other undisclosed noncurrent assets172972(3,477)(3,778)(525)
Total noncurrent assets:1,1961,4861,215274394
TOTAL ASSETS:2,4771,8011,3825771,107
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,0412,5951,8701,5031,473
Accounts payable856680153166158
Accrued liabilities8841,6151,7171,3371,314
Employee-related liabilities300300   
Debt178    
Due to related parties538414204191197
Other undisclosed current liabilities1,5071,4071,881 1,607
Total current liabilities:4,2644,4163,9551,6943,276
Noncurrent Liabilities
Other undisclosed liabilities   2,402 
Total liabilities:4,2644,4163,9554,0963,276
Stockholders' equity
Stockholders' equity attributable to parent, including:(1,195)(2,101)(2,573)(3,519)(2,169)
Preferred stock11111
Common stock2,3501,5821,032771664
Common stock, share subscribed but unissued, subscriptions receivable(655)(382)   
Additional paid in capital136,964127,942110,25691,77186,605
Deferred compensation equity(1,706)(3,209)   
Retained earnings (accumulated deficit)(138,138)(128,017)(109,393)(92,509)86,574
Other undisclosed stockholders' equity attributable to parent(11)(18)(4,470)(3,553)(176,013)
Stockholders' equity attributable to noncontrolling interest(592)(513)   
Total stockholders' equity:(1,787)(2,614)(2,573)(3,519)(2,169)
TOTAL LIABILITIES AND EQUITY:2,4771,8011,3825771,107

Income statement (P&L) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues944134537
Revenue, net   8337
Financial services revenue   262 
Cost of revenue
(Cost of Goods and Services Sold)
(4)(7,252)(3,663)(1,183)(50)
Gross profit:5(7,208)(3,662)(838)(14)
Operating expenses(8,726)(19,063)(15,887)(3,447)(16,669)
Other undisclosed operating income 7,2523,66392050
Operating loss:(8,721)(19,019)(15,886)(3,365)(16,633)
Nonoperating expense(1,478)(119)(998)  
Investment income, nonoperating(972) (90)  
Interest and debt expense(589)(5,625)(5,358)(2,307)(4)
Loss from continuing operations before equity method investments, income taxes:(10,788)(24,762)(22,242)(5,672)(16,636)
Other undisclosed income (loss) from continuing operations before income taxes   (263)600
Net loss:(10,788)(24,762)(22,242)(5,934)(16,037)
Net income attributable to noncontrolling interest78513   
Other undisclosed net income (loss) attributable to parent5105,1125,358 (1)
Net loss attributable to parent:(10,199)(19,137)(16,885)(5,934)(16,038)
Other undisclosed net income available to common stockholders, basic78513   
Net loss available to common stockholders, diluted:(10,121)(18,624)(16,885)(5,934)(16,038)

Comprehensive Income ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(10,788)(24,762)(22,242)(5,934)(16,037)
Other comprehensive income (loss) (3)21  
Comprehensive loss:(10,788)(24,765)(22,221)(5,934)(16,037)
Comprehensive income, net of tax, attributable to noncontrolling interest78513   
Other undisclosed comprehensive income, net of tax, attributable to parent5965,6305,316  
Comprehensive loss, net of tax, attributable to parent:(10,114)(18,621)(16,906)(5,934)(16,037)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: